Reza Zadno - Mar 31, 2022 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
President, CEO, Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Reza Zadno, Ph.D.
Stock symbol
PRCT
Transactions as of
Mar 31, 2022
Transactions value $
$1,154,987
Form type
4
Date filed
4/4/2022, 05:18 PM
Previous filing
Sep 21, 2021
Next filing
Feb 21, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Award $1.15M +39.3K +70.17% $29.38 95.3K Mar 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Award $0 +79.6K $0.00 79.6K Mar 31, 2022 Common Stock 79.6K $34.99 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 15, 2023, with one-quarter of the remaining RSUs vesting annually on each of the second, third, and fourth anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.
F2 The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.